Hanjin Park

Mr. Hanjin Park

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2025 in Environmental Analysis Health and Toxicology
Verified
Journal Article
Open access
AJAriunzaya Jamsranjav
Ariunzaya Jamsranjav
JGJunkyung Gil
Junkyung Gil
DKDonghyun Kim
Donghyun Kim
SCSungbin Choi
Sungbin Choi
HPHanjin Park
Hanjin Park
OBOk-Nam Bae
Ok-Nam Bae
Exposure to toxic heavy metals, such as lead, mercury, arsenic, and cadmium (Pb²⁺, Hg²⁺, As⁵⁺, As³⁺, and Cd²⁺), is a known contributor to neurological dysfunction. Although the individual neurotoxicity of these metals has been well established, their synergistic effects with endogenous neurotoxins such as glutamate remain insufficiently explored. In this study, we investigated neurotoxic effects of the combination of glutamate and heavy metals using the HT-22 hippocampal neuronal cell line. The cells were exposed to each heavy metal alone or in combination with glutamate at low [LCR; glutamate: heavy metal = 1:0.0025] and high [HCR; glutamate: heavy metal = 1:0.025] concentration ratios. Cell viability was measured by the MTT assay, and synergistic effects were quantitatively assessed by the Chou–Talalay method using CompuSyn software. The results showed that Pb²⁺ exhibited consistent synergistic effects with glutamate at both concentration ratios. In addition, Hg²⁺ and As⁵⁺ demonstrated synergistic effects with glutamate under high concentration conditions. These findings highlight that certain heavy metals can potentiate glutamate-induced neurotoxicity through synergistic mechanisms. This study provides quantitative evidence for the enhanced neurotoxic potential of environmental heavy metals when combined with endogenous excitotoxins such as glutamate.

26 January 2026 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
HPHanjin Park
Hanjin Park
SCSungbin Choi
Sungbin Choi
DKDonghyun Kim
Donghyun Kim
EKEun-Hye Kim
Eun-Hye Kim
YBYiying Bian
Yiying Bian
OBOk-Nam Bae
Ok-Nam Bae

Verified
Journal Article
Open access
PDF file
HPHanjin Park
Hanjin Park
OBOk-Nam Bae
Ok-Nam Bae
SCSungbin Choi
Sungbin Choi
ELEunha Lee
Eunha Lee
JCJun Chang
Jun Chang
HCHan Young Chung
Han Young Chung
Adenoviral vector vaccines were pivotal for COVID-19 control, but postmarketing safety surveillance has identified venous-predominant thrombotic risks not fully explained by platelet-centric mechanisms. We tested an RBC-associated hypothesis using an Ad5 vector-rAd/HA(PR8) rat model within a predefined sub-hemolytic window (<10% hemolysis). Ex vivo, we quantified RBC surface phosphatidylserine (PS) exposure, morphology remodeling by scanning electron microscopy, and microvesicle generation, all aligning with increased procoagulant activity. RBCs also exhibited dose-dependent increases in thrombin generation 4 h after intravenous exposure (108–109 OPU/Rat). In vivo, an inferior vena cava thrombosis model showed a pronounced, dose-responsive rise in thrombus burden, consistent with increased thrombogenic potential. Together, these integrated data provide experimental evidence consistent with RBC involvement under adenoviral exposure, supporting a biologically plausible link to the venous-predominant epidemiology observed during the COVID-19 vaccination era. Reported clinical adenoviral vaccine doses are of the same order of magnitude as the exposures tested here, supporting translational relevance while not implying inter-species or product equivalence. Incorporating RBC-focused endpoints, including PS exposure, morphology indices, microvesicle counts, and thrombin generation, into preclinical and early clinical assessments may enhance safety evaluation and inform vector design to mitigate venous thrombotic risk.

6 February 2026 in Science Advances
Verified
Journal Article
Open access
SCSungbin Choi
Sungbin Choi
HPHanjin Park
Hanjin Park
OBOk-Nam Bae
Ok-Nam Bae
YBYiying Bian
Yiying Bian
HIHanhyeok Im
Hanhyeok Im
HCHan Young Chung
Han Young Chung
Enterohemorrhagic Escherichia coli (EHEC) causes thrombotic microangiopathy, yet the red blood cell (RBC)–centered mechanism has remained unclear. We identify the RTX-family hemolysin EhxA as the driver of RBC-mediated thrombogenesis. Deletion of ehxA abolishes Ca 2+ influx, phosphatidylserine (PS) exposure, progression from discocyte to echinocyte to spherocyte, thrombin generation, RBC-endothelium adhesion, and RBC aggregation. Genetic complementation restores these readouts to wild type, and purified EhxA in bacteria-free assays recapitulates them while localizing to intact RBC membranes. By contrast, Δ stx2 mutants do not elicit these RBC phenotypes, distinguishing this pathway from Shiga toxin–dependent effects. Multiple regression quantifies the link between PS exposure, morphology, and procoagulant outputs. In rats, infection with wild type increased RBC remodeling and venous thrombosis, whereas infection with Δ ehxA did not. Together, the data define an EhxA-Ca 2+ -PS pathway that drives RBC structural remodeling and procoagulant activation during EHEC infection and nominate RTX toxins as targets for preventing toxin-induced coagulopathies.